Detalhe da pesquisa
1.
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
Oncologist;
23(12): 1401-1406, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30104292